Ładuje się......
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)
PURPOSE: Sorafenib is a multi-targeted tyrosine kinase inhibitor with therapeutic efficacy in several malignancies. Sorafenib may exert its anti-neoplastic effect in part by altering vascular permeability and reducing intra-tumoral interstitial hypertension. As correlative science with a phase II st...
Zapisane w:
Główni autorzy: | , , , , , , , , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
Public Library of Science
2012
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3274514/ https://ncbi.nlm.nih.gov/pubmed/22347360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0026331 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|